A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
出版年份 2013 全文链接
标题
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
作者
关键词
Generic, Medicine, Drug, Pharmaceutical, Biosimilar, Prescribing, Healthcare, Economics, Ireland
出版物
BMC Pharmacology & Toxicology
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-01-06
DOI
10.1186/2050-6511-14-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment failure in osteoporosis
- (2012) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review
- (2012) Ripple Talati et al. PHARMACOTHERAPY
- Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland
- (2012) Marion Bennie et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Physician Perceptions About Generic Drugs
- (2011) William H Shrank et al. ANNALS OF PHARMACOTHERAPY
- 'Not the full Monty': a qualitative study of seniors' perceptions of generic medicines in Western Australia
- (2011) Caroline Bulsara et al. Australian Journal of Primary Health
- Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe
- (2011) Atholl Johnston et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Changed constitution without change in brand name – The risk of generics in epilepsy
- (2011) Vishal Patel et al. EPILEPSY RESEARCH
- Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists
- (2011) Carlota Quintal et al. HEALTH POLICY
- A reappraisal of generic bisphosphonates in osteoporosis
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Generic and therapeutic substitution: ethics meets health economics
- (2011) Steven Simoens International Journal of Clinical Pharmacy
- European countries with small populations can obtain low prices for drugs: Lithuania as a case history
- (2011) Kristina Garuoliene et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The impact of reference-pricing systems in Europe: a literature review and case studies
- (2011) Pieter Dylst et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Generic and therapeutic substitutions in the UK: are they a good thing?
- (2010) Martin G. Duerden et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effectiveness, safety and cost of drug substitution in hypertension
- (2010) Atholl Johnston et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention
- (2010) Atholl Johnston CURRENT MEDICAL RESEARCH AND OPINION
- Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs
- (2010) Aaron S. Kesselheim et al. DRUGS
- Pharmacoeconomic Evaluation in Ireland
- (2010) Lesley Tilson et al. PHARMACOECONOMICS
- Impact of European Pharmaceutical Price Regulation on Generic Price Competition
- (2010) Jaume Puig-Junoy PHARMACOECONOMICS
- Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland
- (2010) Reeta Heikkilä et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Allergic reaction to Croscarmellose sodium used as excipient of a generic drug
- (2010) N. Mumoli et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications
- (2010) Diane McGinn et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications
- (2010) Brian Godman et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Generic medicine pricing in Europe: current issues and future perspective
- (2010) Steven Simoens JOURNAL OF MEDICAL ECONOMICS
- Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
- (2009) Barbara M Davit et al. ANNALS OF PHARMACOTHERAPY
- Patients’ Perceptions Of Generic Medications
- (2009) William H. Shrank et al. HEALTH AFFAIRS
- Recent National and Regional Drug Reforms in Sweden
- (2009) Björn Wettermark et al. PHARMACOECONOMICS
- Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
- (2009) Johann D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years
- (2008) Karolina A Andersson et al. BMC HEALTH SERVICES RESEARCH
- Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease
- (2008) Aaron S. Kesselheim JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Generic Antiepileptic Drugs: Current Controversies and Future Directions
- (2008) Michael D. Privitera Epilepsy Currents
- Generic olanzapine: health authority opportunity or nightmare?
- (2008) A Aleksander Araszkiewicz et al. Expert Review of Pharmacoeconomics & Outcomes Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More